[ Price : $8.95]
FDA approves a Janssen Biotech BLA for subcutaneous Darzalex Faspro for adult patients with newly diagnosed or relapsed/refractory...[ Price : $8.95]
FDA accepts for review a Bristol Myers Squibb NDA for CC-486, an investigational oral hypomethylating agent for the maintenance tr...[ Price : $8.95]
Alliance for a Stronger FDA says the vaccines development industry is likely to see a renaissance under pressure from the Covid-19...[ Price : $8.95]
FDA grants Gilead Sciences an emergency use authorization for its antiviral drug remdesivir for treating suspected or laboratory-c...[ Price : $8.95]
Three stakeholders comment for the FDA docket on updating the agency data strategy.[ Price : $8.95]
CDER issues a MAPP on its approach to newly identified safety signals in marketed drugs.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled Information Sharing Among Constituent ...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Temporary Policy Regarding Accredited Third-Party Certifica...